by | Jul 7, 2021 | Uncategorized
Source: Healio News Patients with multiple myeloma mounted suboptimal and variable antibody responses to the messenger RNA COVID-19 vaccines, according to study results published in Cancer Cell.Additionally, patients who had not contracted COVID-19 before messenger...
by | Jul 2, 2021 | Uncategorized
Source: Healio News The FDA granted fast track designation to ALLO-605, a chimeric antigen receptor T-cell therapy for adults with relapsed or refractory multiple myeloma.ALLO-605 (Allogene Therapeutics) is an allogeneic, gene-edited CAR T-cell therapy that targets...
by | Jul 1, 2021 | Uncategorized
Source: Cure Today articles Donald Rumsfeld, who died from multiple myeloma, served as secretary of defense under Presidents Gerald R. Ford and George W. Bush. Read More
by | Jun 24, 2021 | Uncategorized
Source: Healio News Cristina Gasparetto, MD, director of the multiple myeloma program at Duke University, discussed data on bispecific T-cell engagers currently being studied in relapsed and refractory multiple myeloma presented at the virtual ASCO Annual MeetingIn a...
by | Jun 24, 2021 | Uncategorized
Source: Healio News Once weekly selinexor, carfilzomib and dexamethasone was highly active and yielded deep responses in patients with heavily pretreated multiple myeloma, according to data presented at the virtual ASCO Annual Meeting.“In patients that we treated at...
by | Jun 24, 2021 | Uncategorized
Source: Healio News Allogeneic hematopoietic cell transplantation showed potential in patients with high-risk multiple myeloma, according to findings presented at the ASCO Annual Meeting.Allogeneic hematopoietic cell transplantation has always been “a very difficult...
